Surgical resection or palliative care for pancreatic cancer with liver oligometastasis
10.3760/cma.j.cn115610-20210219-00082
- VernacularTitle:胰腺癌合并肝脏寡转移：联合切除还是姑息治疗
- Author:
Yinmo YANG
;
Guangnian LIU
- From:
Chinese Journal of Digestive Surgery
2021;20(4):376-380
- CountryChina
- Language:Chinese
-
Abstract:
The prognosis of pancreatic cancer is the worst in all kinds of digestive tract tumors. Fifty percent of pancreatic cancer patients have distant metastasis at the time of diagnosis, and liver is the most common site of metastasis. For pancreatic cancer patients, the presence of distant metastasis has been always considered as an absolute contraindication for surgical resection. However, with the establishment of multidisciplinary team, especially the researches of chemotherapy and targeted drugs and the application of new chemotherapy regimens in recent years, there are more and more evidences which show the survival benefit of surgical resection for some selected patients with liver oligometastasis after systemic chemotherapy. In this paper, the authors review current situation and progress in the treatment strategy for pancreatic cancer with hepatic oligometastasis, further investigate the indication of surgical treatment and evaluate its clinical outcomes.
